Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4

By  

Current Drug Metabolism, Vol. 5, Iss. 5, 2004-01 ,pp. : 415-442

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 990-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism-Based Inactivators as Probes of Cytochrome P450 Structure and Function

By  

Current Drug Metabolism, Vol. 2, Iss. 3, 2001-09 ,pp. : 215-243

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

By Thervet Eric   Legendre Christopher   Beaune Philippe   Anglicheau Dany  

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 37-47

Future Medicine

Access to resources Recommend Favorite

Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4

By  

Current Drug Metabolism, Vol. 9, Iss. 4, 2008-01 ,pp. : 310-322

Bentham Science Publishers

Access to resources Recommend Favorite